What is Amphastar Pharmaceuticals's current debt?

Amphastar Pharmaceuticals (AMPH) reported current debt of $1.67M in Q1 2026.

How has Amphastar Pharmaceuticals's current debt changed year-over-year?

Amphastar Pharmaceuticals's current debt increased by 646.0% year-over-year, from $224K to $1.67M.

What is the long-term trend for Amphastar Pharmaceuticals's current debt?

Over 5 years (2020 to 2025), Amphastar Pharmaceuticals's current debt has grown at a -33.1% compound annual growth rate (CAGR), from $12.26M to $1.64M.

What does current debt mean?

The portion of long-term debt maturing within the next 12 months, requiring refinancing or repayment from operating cash flows.

Amphastar Pharmaceuticals AMPH Current Debt

Current Debt at other companies

PfizerPFE

$3.86B+3.0%

Halozyme TherapeuticsHALO

$208.74M—

ViatrisVTRS

$1.93B+22,619%

Opko HealthOPK

$1.53M+7.2%

AptarGroupATR

$189.05M+18.8%

Amneal Pharmaceuticals, Inc.AMRX

$6.2M-80.5%

Other financials

Income statement

See full

Revenue$171.2M+0.4%

Gross profit$70.3M-17.5%

Operating income$13.6M-63.5%

Net income$6.4M-74.6%

EPS (diluted)$0.14-72.5%

Balance sheet

See full

Cash & equivalents$170.9M-6.5%

Total debt$686.6M+5.2%

Total equity$445.5M—

Total assets$1.6B+1.3%

Cash flow

See full

Operating cash flow$47.8M+36.4%

CapEx$9.5M-11.1%

Free cash flow$38.3M+57.2%

Valuation

See full

Market cap$926.83M-19.9%

Enterprise value$1.44B-11.4%

P/E11.7×+3.5×

P/S1.3×-0.3×

Profitability

See full

Gross margin47.3%-3.2pp

Operating margin16.2%-10.4pp

Net margin11%-8.4pp

FCF margin18.8%-1.8pp

Returns & leverage

See full

Return on equity14.7%—

Debt / equity0.2×—

Current ratio3.9×+0.9×

Where this comes from

Reported directly by Amphastar Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent.

The official record: Amphastar Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Amphastar Pharmaceuticals's current debt.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Amphastar Pharmaceuticals's current debt?: Amphastar Pharmaceuticals (AMPH) reported current debt of $1.67M in Q1 2026.
How has Amphastar Pharmaceuticals's current debt changed year-over-year?: Amphastar Pharmaceuticals's current debt increased by 646.0% year-over-year, from $224K to $1.67M.
What is the long-term trend for Amphastar Pharmaceuticals's current debt?: Over 5 years (2020 to 2025), Amphastar Pharmaceuticals's current debt has grown at a -33.1% compound annual growth rate (CAGR), from $12.26M to $1.64M.
What does current debt mean?: The portion of long-term debt maturing within the next 12 months, requiring refinancing or repayment from operating cash flows.